Responses
Regular and young investigator award abstracts
Checkpoint blockade therapy
223 Racial differences in outcomes for metastatic renal cell carcinoma (mRCC) patients managed on immune-checkpoint inhibitor (ICI) therapy
Compose a Response to This Article
Other responses
No responses have been published for this article.